Our magazine is free!

for living with diabetes

Articles related to "Amylin Pharmaceuticals" »

FDA Approves Bydureon once-weekly treatment for Type 2 diabetes

Tuesday, June 19th, 2012 | 0 Comments
Recently approved T2 treatment Bydureon is becoming available in pharmacies in the USA nationwide this month. The approval was in part based on clinical experience with Byetta (exenatide) injection, a twice-daily form of exenatide that has been available in the U.S. since read more »
""